OpenResearchAlpha

bioRxiv · 18 Nov 2026

False-negative assessment of NanoNewron's NewroBus blood–brain barrier delivery platform in the JAX apical–domain–humanized TfR1 mouse

Ishita Chakraborty, Tao Yin, Luciano D'Adamioh-index 51

0
Citations
no database records one yet
0
Citations in 2026
so far
51
Leading author's h-index
Luciano D'Adamio, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Humanized transferrin receptor 1 (TfR1) mice are frequently used to evaluate blood–brain barrier (BBB) delivery, yet available strains differ in the extent and design of receptor humanization. We compared two NanoNewron NewroBus–based anti-TNFα constructs, NN-841 (D3 TfR1-binding module) and NN-843 (A2 module), in JAX #038212 (humanized apical domain), Cyagen C001584 (human extracellular-domain CDS model), Cyagen C001860 (human extracellular-domain genomic replacement model), and wild-type controls. Thirty mice received intravenous injections and were evaluated 24 h later. Brain parenchymal-fraction signals were reported in all 12 Cyagen mice, but in none of six JAX or 12 wild–type animals. Serum concentrations were measurable in every group and followed the same rank order for both constructs: Cyagen-CDS>Cyagen–HU>wild type >JAX. Mean CDS–to–JAX serum ratios were approximately 13-–fold for both constructs. Compared with the Cyagen–HU strain, the CDS strain showed higher parenchymal concentrations; the ratio of mean parenchymal to mean serum concentration increased prominently for NN–841, but only modestly for NN–843. These findings indicate that model choice influences 24–h circulating concentrations and apparent BBB delivery. Circulating soluble human TfR1–mediated stabilization and endothelial TfR1–dependent transport are plausible, untested explanations for strain-dependent differences. A negative brain-delivery result in JAX #038212 alone cannot be taken as evidence that NewroBus lacks BBB delivery activity

Neuroscience

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Luciano D'Adamio has the highest h-index among the authors (51).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (3)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.
False-negative assessment of NanoNewron's NewroBus blood–brain barrier delivery platform in the JAX apical–domain–humanized TfR1 mouse - QAI OpenResearch